Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Infertility 1 Anovulation 1

Interventions

pembrolizumab 60 Carboplatin 60 Paclitaxel 51 Magnetic Resonance Spectroscopy 42 Specimen Handling 41 Cisplatin 41 Gemcitabine 34 Bevacizumab 31 Docetaxel 30 Leucovorin 27 Doxorubicin 27 Fluorouracil 26 Dexamethasone 25 Cyclophosphamide 25 Pemetrexed 23 Radiotherapy 22 Radiation 22 Oxaliplatin 22 Etoposide 21 durvalumab 20 Nivolumab 20 Vincristine 19 Taxes 19 Rituximab 19 Irinotecan 19 Prednisone 18 Letrozole 18 Capecitabine 17 Lenalidomide 16 Immunoglobulin G 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Clomiphene × 30 days × Clear all

NCT07616973 2026-06-01

LET-CC-TAM

Sana'a University

Phase 3 Active not recruiting

Anovulation, Infertility, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡